TRAP1 and prostate carcinoma: In apparent contradiction to what we observed with our genetic model, pharmacological inhibition of Trap1 and TRAP1 deletion in a prostate cancer model resulted in inhibition of tumor growth [47, 48] and reduced tumor incidence [49], respectively.